1. Home
  2. STVN vs TX Comparison

STVN vs TX Comparison

Compare STVN & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • TX
  • Stock Information
  • Founded
  • STVN 1949
  • TX 1961
  • Country
  • STVN Italy
  • TX Luxembourg
  • Employees
  • STVN N/A
  • TX N/A
  • Industry
  • STVN Containers/Packaging
  • TX Steel/Iron Ore
  • Sector
  • STVN Consumer Discretionary
  • TX Industrials
  • Exchange
  • STVN Nasdaq
  • TX Nasdaq
  • Market Cap
  • STVN 6.2B
  • TX 6.7B
  • IPO Year
  • STVN 2021
  • TX 2006
  • Fundamental
  • Price
  • STVN $23.67
  • TX $30.31
  • Analyst Decision
  • STVN Buy
  • TX Strong Buy
  • Analyst Count
  • STVN 6
  • TX 2
  • Target Price
  • STVN $27.50
  • TX $55.00
  • AVG Volume (30 Days)
  • STVN 343.4K
  • TX 187.2K
  • Earning Date
  • STVN 11-05-2024
  • TX 11-05-2024
  • Dividend Yield
  • STVN 0.24%
  • TX 10.31%
  • EPS Growth
  • STVN N/A
  • TX N/A
  • EPS
  • STVN 0.48
  • TX 0.40
  • Revenue
  • STVN $1,220,254,294.00
  • TX $18,703,544,000.00
  • Revenue This Year
  • STVN $3.01
  • TX $6.85
  • Revenue Next Year
  • STVN $7.16
  • TX $1.60
  • P/E Ratio
  • STVN $49.11
  • TX $73.97
  • Revenue Growth
  • STVN 3.53
  • TX 15.27
  • 52 Week Low
  • STVN $16.56
  • TX $29.16
  • 52 Week High
  • STVN $34.73
  • TX $44.44
  • Technical
  • Relative Strength Index (RSI)
  • STVN 77.49
  • TX 32.79
  • Support Level
  • STVN $19.25
  • TX $31.40
  • Resistance Level
  • STVN $24.90
  • TX $32.95
  • Average True Range (ATR)
  • STVN 1.02
  • TX 0.85
  • MACD
  • STVN 0.38
  • TX -0.19
  • Stochastic Oscillator
  • STVN 78.23
  • TX 26.56

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel, Usiminas and Mining. In its steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The Usiminas segment include iron ore extraction, steel transformation, production of capital goods and logistics. The vast majority of its revenue comes from the steel segment and geographically from Mexico.

Share on Social Networks: